Summary & Overview
CPT 21049: Partial Maxillectomy for Benign Maxillary Tumor
CPT code 21049 denotes an open surgical partial maxillectomy to remove a benign tumor of the maxilla, using an extraoral osteotomy to access and excise a fast-growing or locally destructive lesion. This procedure is clinically significant because tumors of the maxilla can threaten oral function, facial structure, and airway integrity, and may require complex reconstructive planning. Nationally, billing for such complex head and neck surgeries affects hospital surgical volume, specialist reimbursement, and preauthorization practices.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical indications and the typical surgical setting, along with payer-specific coverage considerations, common modifier usage, and related billing practice notes. The publication also summarizes benchmarks for service lines that manage maxillary tumor excisions and highlights relevant policy updates that can affect claim adjudication.
This resource is intended for coding professionals, surgical providers, and policy analysts seeking a clear, national-level briefing on CPT code 21049, its clinical context, and the reimbursement landscape that commonly surrounds major head and neck oncologic and non-oncologic resections.
Billing Code Overview
CPT code 21049 describes an open surgical procedure to remove a benign (noncancerous) tumor of the maxilla (upper jaw). The procedure involves an extraoral osteotomy — cutting into the maxillary bone — followed by a partial maxillectomy to excise a rapidly growing or locally destructive tumor.
-
Service type: Open surgical tumor excision involving bone (partial maxillectomy)
-
Typical site of service: Outpatient surgical center or inpatient hospital operating room
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient presents with a rapidly enlarging, painless mass of the left maxilla causing facial asymmetry, nasal obstruction, and intermittent epistaxis. Imaging (CT and MRI) demonstrates a expansile, well-circumscribed lesion centered in the left maxillary antrum with cortical thinning and partial invasion of the adjacent alveolar process. An incisional biopsy identifies a benign but locally aggressive neoplasm (e.g., odontogenic tumor or benign fibro-osseous lesion) that is threatening orbital floor integrity and dental roots. After multidisciplinary review, the otolaryngology-head & neck surgery team schedules an open extraoral osteotomy with partial maxillectomy to achieve tumor extirpation with clear margins.
Preoperative workflow includes history/physical, dental and ophthalmologic assessments, anesthesia evaluation, cross-sectional imaging, and surgical planning for possible reconstruction. Intraoperative care involves general endotracheal anesthesia, a transfacial (extraoral) approach to the maxilla, osteotomies to mobilize involved bone, removal of the tumor-bearing segment (partial maxillectomy), hemostasis, and immediate reconstruction as indicated (local flap, obturator placement, or microvascular free tissue transfer). Postoperative workflow includes inpatient monitoring for airway, bleeding, and infection, pain control, dental/oral care, and follow-up imaging and pathology review to confirm margins and guide any further therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |